XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based ChemotherapyU. Gatzemeier, Auro del Giglio, Tudor–Eliade Ciuleanu et al.|Journal of Thoracic Oncology|2009Cited by 87